Valeda Light Delivery System

PBM is the use of low levels of light to stimulate cellular activity to provide beneficial effects. The Valeda Light Delivery System is a medical device that uses PBM to improve vision. The Valeda from LumiThera delivers low-intensity, non-coherent, multi-wavelengths of light at 590, 660, and 850 nanometers to the retinal tissue stimulating mitochondrial metabolic activity, increasing available energy for the cells, reducing oxidative stress and inflammation, to improve vision in eyes with early- and intermediate-stage nonexudative (dry) age-related macular degeneration (AMD). It was authorized by the FDA in November 2024.

The Valeda Light Delivery System is intended to provide improved visual acuity in patients with best corrected visual acuity of 20/32 through 20/70 and who have dry age-related macular degeneration (AMD) characterized by:

• The presence of at least 3 medium drusen( > 63 μm and ≤ 125 μm in diameter), or large drusen (> 125 μm in diameter), or non-central geographic atrophy, AND
• The absence of neovascular maculopathy or center-involving geographic atrophy.

After about two years, the Valeda Light Delivery System treatment provides improved mean visual acuity of approximately one line of visual acuity (ETDRS) compared to those not receiving the treatment.

Maybe. PBM is the first treatment shown to improve vision loss associated with dry AMD. LIGHTSITE III provides compelling evidence to support coverage of PBM in an office setting for qualifying patients. We are happy to discuss the billing in more detail.

In the LIGHTSITE III clinical trial, subjects received PBM treatment with the Valeda in nine (9) sessions over three (3) to five (5) weeks every four (4) months, over twenty-four (24) months. February 14, 2025.

Our goal at Piedmont Retina is to make this therapy available to our patients with completive pricing. We hope one day in the future Valeda Light Delivery will be covered by your insurance plan. Until then, please call our office to obtain pricing information.

Not at this time. We are hopeful in the future this therapy will be covered by all insurance types and plans. Until then, we offer competitive pricing for those who elect to pay out of pocket.